{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:48:49Z","timestamp":1789595329050,"version":"build-2803163510"},"reference-count":23,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Metabolic bone disease (MBD) of prematurity predisposes extremely preterm and extremely low birth weight (ELBW) infants to atraumatic fractures. Evidence on fracture reduction after structured Bone Health Programs (BHPs) remains limited. Methods: We conducted a single-center retrospective cohort of NICU admissions (2014\u20132024) with gestational age &lt; 28 weeks and\/or birth weight &lt; 1000 g, comparing a pre-program era with a standardized BHP that incorporated protocolized biochemical surveillance, a week 4 screening radiograph, optimized mineral targets, pharmacist review of parenteral minerals, and \u201chandle-with-care\u201d practices. The study aimed to evaluate whether implementation of a structured BHP reduced fracture incidence and improved biochemical and clinical outcomes in extremely preterm and ELBW infants. Prespecified effect measures were risk ratio (RR), risk difference (RD) with 95% confidence intervals, Fisher\u2019s exact p values, and number needed to treat (NNT). Among infants with fractures, we compared clinical course and biochemical context across eras. Results: Of 708 eligible infants, 221 were born pre-program and 487 post-program with similar baseline characteristics. Fracture incidence decreased from 9.5% (21\/221) to 1.64% (8\/487); RR 0.17 (95% CI 0.08\u20130.38); RD \u22127.86 percentage points; p &lt; 0.001; NNT \u2248 13. Among infants who fractured, length of stay was lower post-program (104.1 \u00b1 28.3 vs. 172.0 \u00b1 91.5 days). Peak alkaline phosphatase and parathyroid hormone were also lower in the post-program era (ALP 501.3 \u00b1 71.2 vs. 972.5 \u00b1 93.5 IU\/L, p = 0.032; PTH 23.1 \u00b1 12.5 vs. 38.4 \u00b1 21.7 pmol\/L, p = 0.027), whereas serum phosphate and 25 OH vitamin D did not differ significantly. The fracture burden per infant decreased following the BHP (1.50 \u00b1 0.53 vs. 3.19 \u00b1 3.08, p = 0.024). Age at first fracture was earlier post-program, consistent with scheduled imaging (48.4 \u00b1 34.9 vs. 83.9 \u00b1 37.3 days, p = 0.031). Conclusions: A structured BHP was associated with a large reduction in fracture incidence and more favorable biochemical profiles, together with shorter hospitalization among fracture cases. Program elements that combine scheduled imaging, biochemical triggers, nutritional optimization, parenteral mineral stewardship, and standardized handling may improve skeletal outcomes. Multicenter prospective evaluations should confirm generalizability and define core components.<\/jats:p>","DOI":"10.3390\/children12111574","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:03:15Z","timestamp":1763564595000},"page":"1574","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fractures Associated with Metabolic Bone Disease in Extremely Preterm and Extremely Low Birth Weight Infants Before and After a Bone Health Program"],"prefix":"10.3390","volume":"12","author":[{"given":"Saif","family":"Alsaif","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Department, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs, Riyadh 11426, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia"},{"name":"College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Alsherbini","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Department, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs, Riyadh 11426, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0945-0473","authenticated-orcid":false,"given":"Talal","family":"Aljarbou","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Department, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs, Riyadh 11426, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9698-3055","authenticated-orcid":false,"given":"Manal","family":"Alshareef","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Department, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs, Riyadh 11426, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5516-717X","authenticated-orcid":false,"given":"Kamal","family":"Ali","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Department, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs, Riyadh 11426, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia"},{"name":"College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Faienza, M.F., D\u2019Amato, E., Natale, M.P., Grano, M., Chiarito, M., Brunetti, G., and D\u2019Amato, G. (2019). Metabolic Bone Disease of Prematurity: Diagnosis and Management. Front. Pediatr., 7.","DOI":"10.3389\/fped.2019.00143"},{"key":"ref_2","first-page":"40","article-title":"Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations","volume":"98","author":"Grover","year":"2025","journal-title":"Horm. Res. Paediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1067\/mpd.2000.108953","article-title":"Neonatal factors predicting childhood height in preterm infants: Evidence for a persisting effect of early metabolic bone disease?","volume":"137","author":"Fewtrell","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/0148607113499590","article-title":"Metabolic bone disease: A continued challenge in extremely low birth weight infants","volume":"38","author":"Viswanathan","year":"2014","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00003086-199702000-00023","article-title":"Fractures in very low birth weight infants with rickets","volume":"335","author":"Dabezies","year":"1997","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"F82","DOI":"10.1136\/fn.86.2.F82","article-title":"Skeletal development in premature infants: A review of bone physiology beyond nutritional aspects","volume":"86","author":"Rauch","year":"2002","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hogberg, U., Andersson, J., Hogberg, G., and Thiblin, I. (2018). Metabolic bone disease risk factors strongly contributing to long bone and rib fractures during early infancy: A population register study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208033"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1097\/pq9.0000000000000723","article-title":"Reducing Osteopenia of Prematurity-related Fractures in a Level IV NICU: A Quality Improvement Initiative","volume":"9","author":"Cromwell","year":"2024","journal-title":"Pediatr. Qual. Saf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MPG.0000000000003642","article-title":"Enteral Nutrition in Preterm Infants (2022): A Position Paper From the ESPGHAN Committee on Nutrition and Invited Experts","volume":"76","author":"Embleton","year":"2023","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"F72","DOI":"10.1136\/archdischild-2013-304061","article-title":"Balancing the risks and benefits of parenteral nutrition for preterm infants: Can we define the optimal composition?","volume":"100","author":"Embleton","year":"2015","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5662\/wjm.v5.i3.115","article-title":"Metabolic bone disease in the preterm infant: Current state and future directions","volume":"5","author":"Rehman","year":"2015","journal-title":"World J. Methodol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01202412-198909030-00012","article-title":"Fractures and rickets in very low birth weight infants: Conservative management and outcome","volume":"9","author":"Koo","year":"1989","journal-title":"J. Pediatr. Orthop."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/07853899608999080","article-title":"Metabolic bone disease of prematurity","volume":"28","author":"Backstrom","year":"1996","journal-title":"Ann. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01241398-198801000-00010","article-title":"Fractures in premature infants","volume":"8","author":"Amir","year":"1988","journal-title":"J. Pediatr. Orthop."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1542\/peds.2012-0462","article-title":"Prevalence and characteristics of rib fractures in ex-preterm infants","volume":"130","author":"Butler","year":"2012","journal-title":"Pediatrics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1651-2227.2012.02640.x","article-title":"Fractures in a tertiary Neonatal Intensive Care Unit in Wales","volume":"101","author":"Wei","year":"2012","journal-title":"Acta Paediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/jp.2014.97","article-title":"Parathyroid hormone as a marker for metabolic bone disease of prematurity","volume":"34","author":"Moreira","year":"2014","journal-title":"J. Perinatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e4837","DOI":"10.1097\/MD.0000000000004837","article-title":"Serial serum alkaline phosphatase as an early biomarker for osteopenia of prematurity","volume":"95","author":"Abdallah","year":"2016","journal-title":"Medicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101086","DOI":"10.1016\/j.siny.2020.101086","article-title":"Screening for Metabolic Bone Disease of prematurity","volume":"25","author":"Rayannavar","year":"2020","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1542\/peds.2012-3395","article-title":"Trial of daily vitamin D supplementation in preterm infants","volume":"133","author":"Natarajan","year":"2014","journal-title":"Pediatrics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/ejhpharm-2016-001143","article-title":"Experience of compounding total parenteral nutrition admixtures for preterm infants in a hospital pharmacy: Evidence of calcium and phosphate compatibility problem","volume":"25","author":"Zenoni","year":"2018","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1203\/00006450-199901000-00017","article-title":"Dual energy x-ray absorptiometry of the forearm in preterm and term infants: Evaluation of the methodology","volume":"45","author":"Sievanen","year":"1999","journal-title":"Pediatr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cerar, S., Paro-Panjan, D., and Soltirovska-Salamon, A. (2023). The role of quantitative ultrasound in diagnosing severe bone metabolic diseases in newborns. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1109553"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/12\/11\/1574\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:27:20Z","timestamp":1763566040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/12\/11\/1574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["children12111574"],"URL":"https:\/\/doi.org\/10.3390\/children12111574","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}